Oncolytics Biotech (ONCY) Current Leases (2009 - 2025)

Oncolytics Biotech (ONCY) has 9 years of Current Leases data on file, last reported at $193000.0 in Q4 2025.

• On a quarterly basis, Current Leases fell 2.67% year-over-year to $193000.0 in Q4 2025; TTM through Dec 2025 was $193000.0, a 2.67% decrease from a year earlier, with the FY2025 full-year figure at $193000.0, down 3.5% from the prior year.
• Current Leases for Q4 2025 stood at $193000.0, down from $198290.2 in the prior quarter.
• Over the last five years, Current Leases for ONCY reached as high as $233240.8 in Q4 2021 and fell as low as $97693.2 in Q4 2023.
• Historically, Current Leases has averaged $176270.4 across 5 years, with a median of $193000.0 in 2025.
• Across the five-year window, Current Leases tumbled 38.61% in 2023 and surged 102.97% in 2024, its largest moves.
• Year by year, Current Leases stood at $233240.8 in 2021, then sank by 31.78% to $159127.8 in 2022, then slumped by 38.61% to $97693.2 in 2023, then jumped by 102.97% to $198290.2 in 2024, then retreated by 2.67% to $193000.0 in 2025.
• Per Business Quant data, the three most recent Current Leases figures were $193000.0 in Q4 2025, $198290.2 in Q4 2024, and $97693.2 in Q4 2023.